The global sentinel node biopsy market is estimated to be valued at USD 806.3 Mn in 2025 and is expected to reach USD 1,312.7 Mn by 2032, exhibiting a compound annual growth rate (CAGR) of 7.2% from 2025 to 2032.
To learn more about this report, Request sample copy
The market is expected to witness lucrative growth over the forecast period owing to rising awareness about minimally invasive cancer staging techniques among patients and doctors. Technological advancements in imaging solutions to detect sentinel lymph nodes accurately is another key factor augmenting the demand for sentinel node biopsy. Adoption of robot-assisted sentinel lymph node biopsy systems will further support revenue generation in the coming years.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients